Skip to content
LawCrust
Practices · Healthcare & Life Sciences

Healthcare & Life Sciences · India · UAE · USA

Regulatory advisory for hospitals, pharma, medical devices, biotech, and digital health, drug and clinical-trial regulation, DCGI approvals, telemedicine compliance, healthcare data privacy, and medical-negligence dispute defence.

Scope of Work

What We Deliver Under Healthcare & Life Sciences.

The named, recurring work an enterprise client engages us for in this practice. Adjacent matters are common, scoped on the call.

  • Drug and clinical-trial regulation; DCGI approvals and CDSCO compliance
  • Medical-device classification and registration
  • Telemedicine practice guidelines and digital-health compliance
  • Hospital licensing, NABH / NABL coordination, and operational compliance
  • Medical-negligence dispute defence (consumer fora and civil courts)
  • Healthcare data privacy intersected with our DPDP / HIPAA work

Who it's for

The Buyer Profile.

Hospital chains, pharma and biotech companies, medical-device manufacturers, telemedicine and digital-health startups, contract research organisations (CROs), and foreign life-sciences companies entering the Indian market.

Regulators & Frameworks

Bodies and frameworks we operate under.

  • CDSCO
  • DCGI
  • NPPA
  • State drug controllers
  • Medical councils

How we engage

From Scoping Call to First Deliverable.

  1. 01

    Scoping call

    A 45-minute conversation to understand your matter, jurisdictions, and operating cadence. Initial calls are nominal.

  2. 02

    Engagement letter

    Scope, fees, escalation paths, and SLAs in writing within 2-5 business days.

  3. 03

    Onboarding

    Secure document handover, system access, named counsel allocated.

  4. 04

    Delivery & reviews

    Monthly drumbeat for retainers, quarterly business reviews where the matter calls for it.

Healthcare & Life Sciences, Frequently Asked

Questions buyers ask before engaging.

Do you handle DCGI approvals and clinical-trial regulation?

Yes. Investigational New Drug (IND), New Drug Application (NDA), and Clinical Trial Application (CTA) work, plus ongoing CDSCO compliance and pharmacovigilance advisory.

Can you advise telemedicine and digital-health businesses?

Yes. The Telemedicine Practice Guidelines, prescription validity, doctor-patient consent flows, and the data-protection overlay for health data are routine for telemedicine-platform clients.

Do you defend medical-negligence claims?

Yes, defending hospitals and individual practitioners across consumer fora (DCDRC, NCDRC) and civil courts. Strategy, expert-witness coordination, and settlement negotiations are part of the scope.

General questions on engagement, security, and procurement live on the FAQ page.

Related Practices

Buyers of Healthcare & Life Sciences Often Also Engage On.

Bring Us the Healthcare & Life Sciences Matter.

First conversation is nominal. Engagement letter in 2-5 business days. NDAs / DPAs returned within two business days.